Procter & Gamble Health Stock Screener | Share Price & Fundamental Analysis
PGHL
Pharmaceuticals
Share Price NSE
₹5019.50
▲
2.00 (0.04%)
Share Price BSE
₹5016.75
▼
-0.70 (-0.01%)
Track Procter & Gamble Health share price live with TickJournal's free stock screener.
Analyze Procter & Gamble Health share price history trends and compare 52-week high low
levels.
Calculate PGHL stock fair value using fundamental analysis and view live share price charts.
Determine Procter & Gamble Health share intrinsic value and compare it with current PGHL share price.
Record your Procter & Gamble Health trades in TickJournal's free trading journal and track your portfolio performance.
Procter & Gamble Health Market Cap
₹8,281.43 Cr.
PGHL P/E Ratio (TTM)
29.18
EPS (TTM)
₹141.00
Dividend Yield
2.42%
Debt to Equity
0.01
PGHL 52 Week High
₹6581.50
Procter & Gamble Health 52 Week Low
₹4989.00
Operating Margin
30.00%
Profit Margin
21.54%
PGHL Revenue (TTM)
₹1,365.00
EBITDA
₹418.00
Net Income
₹294.00
Total Assets
₹794.00
Total Equity
₹537.00
Procter & Gamble Health Share Price History - Stock Screener Chart
Screen PGHL historical share price movements with interactive charts. Analyze price trends and patterns.
Procter & Gamble Health Company Profile - Fundamental Screener
Screen Procter & Gamble Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PGHL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE199A01012
Procter & Gamble Health Balance Sheet Screener
Screen PGHL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 | 784 |
| Current Assets | 526 | 524 | 796 | 608 | 727 | 954 | 1,534 | 752 | 636 | 572 |
| Fixed Assets | 116 | 129 | 144 | 112 | 104 | 101 | 104 | 115 | 111 | 132 |
| Liabilities | ||||||||||
| Total Liabilities | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 | 784 |
| Current Liabilities | 42 | 37 | 46 | 40 | 44 | 42 | 27 | 33 | 29 | 27 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 537 | 538 | 751 | 617 | 704 | 906 | 1,540 | 733 | 664 | 592 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 520 | 522 | 734 | 600 | 687 | 890 | 1,524 | 717 | 647 | 575 |
Procter & Gamble Health Income Statement Screener - Profit & Revenue Analysis
Screen Procter & Gamble Health income statement and profit fundamentals.
Analyze PGHL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Procter & Gamble Health share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,365 | 945 | 1,167 | 1,248 | 1,128 | 1,027 | 1,425 | 873 | 722 | 1,017 | 963 |
| Expenses | 947 | 616 | 845 | 905 | 847 | 763 | 1,041 | 701 | 621 | 877 | 856 |
| EBITDA | 418 | 329 | 322 | 343 | 281 | 264 | 384 | 173 | 101 | 140 | 107 |
| Operating Profit % | 30.00% | 34.00% | 27.00% | 26.00% | 24.00% | 24.00% | 23.00% | 17.00% | 11.00% | 12.00% | 9.00% |
| Depreciation | 23 | 17 | 27 | 28 | 27 | 30 | 30 | 21 | 19 | 25 | 23 |
| Interest | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 395 | 312 | 273 | 314 | 253 | 233 | 355 | 158 | 99 | 115 | 83 |
| Tax | 107 | 77 | 72 | 85 | 61 | 57 | 101 | 56 | 38 | 36 | 30 |
| Net Profit | 294 | 234 | 201 | 230 | 193 | 177 | 254 | 102 | 61 | 79 | 54 |
| EPS | 176.80 | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | 153.00 | 505.27 | 56.60 | 47.70 | 32.30 |
Procter & Gamble Health Cash Flow Screener - Liquidity Fundamentals
Screen PGHL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 169 | 228 | 236 | 170 | 247 | 235 | -130 | 54 | 107 | 84 |
| Investing Activities | 10 | -7 | -22 | -26 | -32 | 165 | 1,270 | -48 | -75 | -68 |
| Financing Activities | -235 | -418 | -99 | -289 | -387 | -883 | -30 | -22 | -15 | -12 |
| Net Cash Flow | -57 | -197 | 116 | -145 | -172 | -483 | 1,109 | -16 | 17 | 4 |
Procter & Gamble Health Shareholding Pattern Screener
See Procter & Gamble Health shareholding pattern with promoter, FII, and DII holdings.
Check Procter & Gamble Health promoter holding and ownership changes for PGHL on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FII Holding | 6.87% | 6.99% | 7.24% | 6.97% | 6.24% | 6.40% | 6.61% | 7.02% |
| DII Holding | 14.21% | 14.16% | 13.91% | 13.84% | 13.73% | 14.55% | 14.84% | 14.71% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 21.90% | 21.89% | 22.15% | 22.43% | 22.61% | 21.82% | 21.46% | 21.34% |
| Other Holding | 5.21% | 5.14% | 4.89% | 4.94% | 5.60% | 5.41% | 5.28% | 5.12% |
| Shareholder Count | 53,993 | 52,478 | 50,006 | 49,302 | 56,778 | 55,923 | 54,792 | 53,736 |
Procter & Gamble Health Share Dividend Screener - Share Yield Analysis
Check Procter & Gamble Health dividend history with payout and yield data.
View Procter & Gamble Health dividend details including ex-dates and amounts for PGHL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹125.00 | 2.51% |
| 2024-March | ₹260.00 | 5.05% |
| 2023-March | ₹95.00 | 2.02% |
| 2022-March | ₹52.50 | 1.12% |
| 2021-March | ₹130.00 | 3.25% |
| 2020-March | ₹230.00 | 3.71% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹440.00 | 11.91% |
| 2017-March | ₹15.00 | 1.00% |
Procter & Gamble Health Stock Index Membership
See which indices include Procter & Gamble Health stock.
Check PGHL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Procter & Gamble Health Market Events Screener - Corporate Actions
Get Procter & Gamble Health corporate actions including splits, bonuses, and buybacks.
Check Procter & Gamble Health stock events that may affect PGHL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 110.00 /share | 4.56% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 50.00 /share | 4.56% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -6.98% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.34% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | 1.83% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 45.00 /share | 10.63% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 0.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 5.91% |
| 2025-02-21 | 2025-02-21 | Dividend | ₹ 80.00 /share | 1.63% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.43% |
| 2024-12-05 | 2024-12-05 | Annual General Meeting | NA | -0.50% |
| 2024-11-28 | 2024-11-29 | Dividend | ₹ 60.00 /share | -4.69% |
| 2024-11-04 | 2024-11-04 | Quarterly Result Announcement | NA | -1.04% |
| 2024-02-14 | 2024-02-14 | Dividend | ₹ 150.00 /share | 7.15% |
| 2024-02-14 | 2024-02-14 | Dividend | ₹ 50.00 /share | 7.15% |
Procter & Gamble Health Competitors Screener - Peer Comparison
Screen PGHL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
Procter & Gamble Health Company Announcements - News Screener
Screen PGHL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-13 | Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-13 | Record Date | View |
| 2026-02-13 | Unaudited Financial Results For The Quarter Ended December 31 2025 | View |
| 2026-02-13 | Corporate Action-Board approves Dividend | View |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 6 2026 | View |
| 2026-01-21 | Update on board meeting | View |
| 2026-01-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-26 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On February 6 2026. | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-11-18 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-05 | Outcome Of Board Meeting For The Quarter Ended September 30 2025 | View |
| 2025-11-05 | Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended September 30 2025 | View |
| 2025-10-20 | Revision of Board Meeting | View |
| 2025-10-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Allotment Of DIN To Mr. Shashank Srowthy Executive Director | View |
| 2025-09-29 | Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 5 2025 | View |